LifeCore Biomedical Files Definitive Proxy Statement
Ticker: LFCR · Form: DEF 14A · Filed: Feb 27, 2025 · CIK: 1005286
| Field | Detail |
|---|---|
| Company | Lifecore Biomedical, Inc. \De\ (LFCR) |
| Form Type | DEF 14A |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
Related Tickers: LFCR
TL;DR
LFCR filed proxy docs, shareholders vote soon.
AI Summary
LifeCore Biomedical, Inc. filed a Definitive Proxy Statement (DEF 14A) on February 27, 2025. This filing concerns the company's proxy materials, likely related to upcoming shareholder meetings or votes. The company, formerly known as Landec Corp, is incorporated in Delaware and headquartered in Chaska, MN.
Why It Matters
Proxy statements are crucial for shareholders to understand company proposals, executive compensation, and director elections before they vote, impacting corporate governance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not inherently indicate new risks.
Key Numbers
- 20250227 — Filing Date (The date the DEF 14A was filed with the SEC.)
Key Players & Entities
- LIFECORE BIOMEDICAL, INC. (company) — Registrant
- LANDEC CORP (company) — Former Company Name
- 0001005286-25-000041 (document_id) — Accession Number
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a Definitive Proxy Statement filed with the SEC, providing shareholders with information about matters to be voted on at a shareholder meeting.
When was LifeCore Biomedical, Inc. previously known by another name?
LifeCore Biomedical, Inc. was formerly known as Landec Corp, with a date of name change on December 22, 1995.
Where is LifeCore Biomedical, Inc. headquartered?
LifeCore Biomedical, Inc. is headquartered at 3515 Lyman Boulevard, Chaska, MN 55318.
What is the Standard Industrial Classification (SIC) code for LifeCore Biomedical, Inc.?
The SIC code for LifeCore Biomedical, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for LifeCore Biomedical, Inc.?
The fiscal year end for LifeCore Biomedical, Inc. is 0525.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on February 27, 2025 regarding LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).